Image Source: India TV News
Agencies:
Drug firm Zydus Cadila today said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19 in the Indian market.
Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory filing.
The Company said the drug will be made available across India through the group�s strong distribution chain reaching out to Government and Private hospitals treating COVID-19 patients.
Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of COVID-19, Cadila Healthcare Managing Director Dr. Sharvil Patel said.
Leave a comment: (Your email will not be published)